Pancreatic Cancer Research

ResearcherRutgers, The State University of New JerseyActive in the last 2 years

Nirag Chandrakant Jhala

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112267628, A5112695292. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 8

  1. Molecular Tests in Pancreatic Cancer: Critical Role of Molecular Testing, Expanding Access, and Adherence to the NCCN Guidelines for Pancreatic Cancer. Co-author DOI 10.6004/jnccn.2024.7050↗
  2. Standardisation of EUS-guided FNB technique for molecular profiling in pancreatic cancer: results of a randomised trial. First author DOI 10.1136/gutjnl-2023-329495↗
  3. Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance. Co-author DOI 10.1002/ijc.32108↗
  4. A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer. Co-author DOI 10.1007/s00280-018-3519-6↗
  5. A Rare Multifocal Pattern of Type 2 Autoimmune Pancreatitis with Negative IgG4: A Potential Diagnostic Pitfall That May Mimic Multifocal Pancreatic Adenocarcin… Co-author DOI 10.1159/000486443↗
  6. Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer. Co-author DOI 10.1002/pmic.201500133↗
  7. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Co-author DOI 10.1016/j.ccr.2012.04.025↗
  8. A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally… Co-author DOI 10.1007/s00280-010-1383-0↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. J M Petersen · 1 shared paper, 2024 · strength 0.36
  2. Darshana N Jhala · 1 shared paper, 2024 · strength 0.36
  3. Shyam Varadarajulu · 2 shared papers, 2011–2023 · strength 0.22
  4. Udayakumar Navaneethan · 1 shared paper, 2023 · strength 0.19
  5. Ji Young Bang · 1 shared paper, 2023 · strength 0.19
  6. Tong Zhou · 1 shared paper, 2019 · strength 0.11
  7. Yong Sun · 1 shared paper, 2019 · strength 0.11
  8. Fei Xu · 1 shared paper, 2019 · strength 0.11
  9. Yabing Chen · 1 shared paper, 2019 · strength 0.11
  10. Shanzhong Yang · 1 shared paper, 2019 · strength 0.11
  11. Omar Agosto · 1 shared paper, 2018 · strength 0.11
  12. Partha V. Hota · 1 shared paper, 2018 · strength 0.11
  13. Donald J Buchsbaum · 2 shared papers, 2011–2016 · strength 0.08
  14. Peter James O'Dwyer · 1 shared paper, 2018 · strength 0.06
  15. Charles M. Vollmer · 1 shared paper, 2018 · strength 0.06
  16. Jacob Ezra Shabason · 1 shared paper, 2018 · strength 0.06
  17. John Peter Plastaras · 1 shared paper, 2018 · strength 0.06
  18. Edgar Ben‐Josef · 1 shared paper, 2018 · strength 0.06
  19. Jeffrey A. Drebin · 1 shared paper, 2018 · strength 0.06
  20. James M. Metz · 1 shared paper, 2018 · strength 0.06
  21. Mark H. O’Hara · 1 shared paper, 2018 · strength 0.06
  22. Kim A. Reiss · 1 shared paper, 2018 · strength 0.06
  23. Christopher Klug · 1 shared paper, 2016 · strength 0.06
  24. Michael Ludwig · 1 shared paper, 2016 · strength 0.06
  25. James A. Mobley · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.